In a study, PAX5 deletions decreased leukemia cell viability by inducing apoptotic cell death using a new ribozyme-derived isotype-specific knockdown system in the B-ALL cell model (77). Here, PAX5 is linked to precursor B-cell acute lymphoblastic leukemia.